Search Results 1111-1120 of 17886 for Embolism

  1. A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements. - Mayo Clinic

    ... embolism);; Prolonged QT syndrome (or triplicate average QTc corrected using Fridericia's formula [QTcF] > 470 msec at screening);; Presence of ongoing Grade ...

  2. Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies - Mayo Clinic

    Arterial thrombotic or embolic ... Venous thrombotic events (eg, deep vein thrombosis) or pulmonary arterial events (eg, pulmonary embolism) within 3 months ...

  3. Mayo Clinic

    ... . IMG-20076418. Home; my01593-pick-a-pear-or-a-plum-or-an-apple. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be ...

  4. Joint Replacement Surgery Clinical Trials - Mayo Clinic Research

    Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement Scottsdale/Phoenix, AZ. PEPPER is a randomized study comparing the ...

  5. Publications - Sushil Sonavane, M.B.B.S., M.D. - Mayo Clinic

    The RSNA Pulmonary Embolism CT Dataset. Radiol Artif Intell. 2021 Mar; 3 (2):e200254 Epub 2021 Jan 20. View PubMed; Baruah D, Sonavane S, Goodman L, Nath H ...

  6. Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung - Mayo Clinic

    History of cerebrovascular accident including transient ischemic attack (TIA), pulmonary embolism or untreated deep venous thrombosis (DVT) within the past 6 ...

  7. Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) - Mayo Clinic

    Subjects with a history of TEE such as deep vein thrombosis, pulmonary embolism, myocardial infarction, ischemic stroke, transient ischemic attack, peripheral ...

  8. A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label - Mayo Clinic

    Significant thrombotic or embolic events within 3 months prior to randomization (significant thrombotic or embolic events include but are not limited to stroke ...

  9. Radiology - Doctors - Mayo Clinic

    ... embolism, Pulmonary arteriovenous malformation, Chronic pulmonary thromboembolism, Chylothorax, Lung tumor, Chylous ascites, Chylous effusion. Show more ...

  10. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

    History of pulmonary embolism, deep vein thrombosis, or prior clinically significant venous or non-CVA/TIA arterial thromboembolic event (e.g., internal ...